According to the Advocate General’s interpretation of the Directive and related soft law (i.e., MEDEV guidelines), software allowing the prescriber to detect contraindications, drug interactions and excessive doses shall qualify as a medical device.
There is still much to learn about the benefits and potential of robotic surgery.
The new MDR introduces several changes that manufacturers must consider right away.
Uncertainty caused by Britain’s EU departure creates opportunity for its neighbor.
The 1000-dollar genome presents a big opportunity in medicine.
The healthcare landscape is changing, and technologies are racing to meet new demands.
Should you trust your health to Artificial Intelligence?
A look at the latest trends and cutting-edge products provides plenty of examples.
Medtech manufacturers are taking advantage of this global opportunity.
The agency continues to take measures to ensure the safety and quality of imported medical devices.